{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:57:29Z","timestamp":1792033049642,"version":"4.4.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) influenced by multiple factors. Berberine, an isoquinoline alkaloid derived from the root and bark of <jats:italic>Coptis chinensis<\/jats:italic> Franch., has shown promise in managing UC, but its underlying mechanisms remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To elucidate the relationship between berberine, ulcerative colitis (UC), and the organism\u2019s metabolome, we established a dextran sulfate sodium (DSS)-induced UC model in rats. Colonic tissue was collected for histopathological examination, while plasma samples were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS\/MS) with dynamic Multiple Reaction Monitoring (dMRM). This approach, characterized by its short analysis time of 20\u00a0min per sample, excellent reproducibility, and straightforward data processing, allowed for the comprehensive detection of a wide array of metabolites, including amino acids, lipids, and organic acids, many of which are implicated in the pathophysiology of UC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results showed that berberine modulated the metabolic disturbances of 33 compounds in the plasma of UC rats, primarily including amino acids, pyrimidines, organic phosphoric acids, fatty acyls, and organonitrogen compounds. These altered metabolites were associated with various pathways, such as amino acid metabolism, glutathione metabolism, nicotinate and nicotinamide metabolism, taurine and hypotaurine metabolism, pyrimidine metabolism, glyoxylate and dicarboxylate metabolism, and the citrate cycle (TCA cycle). Notably, 3-hydroxyproline, homocysteic acid, <jats:italic>L<\/jats:italic>-threonine, <jats:italic>L<\/jats:italic>-lysine, carbamoyl phosphate, <jats:italic>O<\/jats:italic>-phosphoethanolamine, taurine, leucine, and phosphorylcholine exhibited significant differences between the Treatment and Model groups, with levels reverting to those of the Control group (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). These findings suggested that these compounds may serve as potential plasma biomarkers for UC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provided valuable insights into the mechanism by which berberine exerted its therapeutic effects on UC through metabolomics. Our results highlighted berberine\u2019s potential to modulate key metabolic pathways and restore the levels of several metabolites, suggesting its utility as a therapeutic agent for UC. These findings underscored the importance of metabolomics in understanding the pathophysiology and treatment of UC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fchem.2024.1518110","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T04:45:57Z","timestamp":1733892357000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive plasma metabolomics analysis of berberine treatment in ulcerative colitis rats by LC-MS\/MS"],"prefix":"10.3389","volume":"12","author":[{"given":"Baodong","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"B1","first-page":"23","article-title":"Extradigestive manifestations of IBD in pediatrics","volume":"13","author":"Aloi","year":"2009","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpba.2014.12.017","article-title":"Metabolomics for laboratory diagnostics","volume":"113","author":"Bujak","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B3","doi-asserted-by":"publisher","first-page":"934145","DOI":"10.3389\/fonc.2022.934145","article-title":"UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"115582","DOI":"10.1016\/j.jpba.2023.115582","article-title":"UHPLC-HRMS-based serum untargeted lipidomics: phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer","volume":"234","author":"Chen","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/metabo10090348","article-title":"Bridging targeted and untargeted mass spectrometry-based metabolomics via hybrid approaches","volume":"10","author":"Chen","year":"2020","journal-title":"Metabolites"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jfma.2018.09.007","article-title":"Metabolome analysis for investigating host-gut microbiota interactions","volume":"118","author":"Chen","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1021\/ac4016787","article-title":"Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography\/triple quadrupole mass spectrometry","volume":"85","author":"Chen","year":"2013","journal-title":"Anal. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/nu11010025","article-title":"The role of succinate in the regulation of intestinal inflammation","volume":"11","author":"Connors","year":"2018","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1038\/s41598-022-06886-1","article-title":"Comparative systeomics to elucidate physiological differences between CHO and SP2\/0 cell lines","volume":"12","author":"Demirhan","year":"2022","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jcis.2024.05.162","article-title":"Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy","volume":"671","author":"Deng","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00285-024-02117-5","article-title":"Homeostasis in networks with multiple inputs","volume":"89","author":"De Oliveira Madeira","year":"2024","journal-title":"J. Math. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","article-title":"The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research","volume":"1277","author":"Emwas","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"B13","first-page":"27","article-title":"Morphology of inflammatory bowel diseases (IBD)","volume":"58","author":"Fabi\u00e1n","year":"2022","journal-title":"Cesk Patol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.3390\/ijms232415805","article-title":"Untargeted NMR metabolomics reveals alternative biomarkers and pathways in alkaptonuria","volume":"23","author":"Grasso","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/evan.21825","article-title":"Studying human and nonhuman primate evolutionary biology with powerful in vitro and in vivo functional genomics tools","volume":"29","author":"Grogan","year":"2020","journal-title":"Evol. Anthropol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1002\/jssc.202200255","article-title":"Comprehensive pseudotargeted metabolomics analysis based on two-phase liquid extraction-UHPLC-MS\/MS for the investigation of depressive rats","volume":"45","author":"Huang","year":"2022","journal-title":"J. Sep. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ibd\/izab256","article-title":"Fecal amino acid analysis in newly diagnosed pediatric inflammatory bowel disease: a multicenter case-control study","volume":"28","author":"Jagt","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"121848","DOI":"10.1016\/j.jchromb.2019.121848","article-title":"LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats","volume":"1133","author":"Liao","year":"2019","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"124133","DOI":"10.1016\/j.jchromb.2024.124133","article-title":"A pseudo-targeted metabolomics for discovery of potential biomarkers of cardiac hypertrophy in rats","volume":"1240","author":"Liu","year":"2024","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/med.21893","article-title":"Inflammatory bowel disease biomarkers","volume":"42","author":"Liu","year":"2022","journal-title":"Med. Res. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1021\/acs.analchem.5b00615","article-title":"Multiple reaction monitoring-ion pair finder: a systematic approach to transform nontargeted mode to pseudotargeted mode for metabolomics study based on liquid chromatography-mass spectrometry","volume":"87","author":"Luo","year":"2015","journal-title":"Anal. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"922488","DOI":"10.3389\/fphar.2022.922488","article-title":"The application of UHPLC-HRMS for quality control of traditional Chinese medicine","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"882487","DOI":"10.3389\/fmolb.2022.882487","article-title":"Studying metabolism by NMR-based metabolomics","volume":"9","author":"Moco","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1080\/03007995.2021.1968813","article-title":"Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis","volume":"37","author":"Paridaens","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"B25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cgh.2015.06.001","article-title":"Defining disease severity in inflammatory bowel diseases: current and future directions","volume":"14","author":"Peyrin-Biroulet","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted metabolomics strategies-challenges and emerging directions","volume":"27","author":"Schrimpe-Rutledge","year":"2016","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"B27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","article-title":"Biological properties and clinical applications of berberine","volume":"14","author":"Song","year":"2020","journal-title":"Front. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1042\/ebc20180003","article-title":"Systems biology primer: the basic methods and approaches","volume":"62","author":"Tavassoly","year":"2018","journal-title":"Essays Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/biom13111620","article-title":"Kinase signaling in colitis-associated colon cancer and inflammatory bowel disease","volume":"13","author":"Temby","year":"2023","journal-title":"Biomolecules"},{"key":"B30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3748\/wjg.v29.i3.450","article-title":"Seronegative spondyloarthropathy-associated inflammatory bowel disease","volume":"29","author":"Wang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s12885-024-12321-7","article-title":"UHPLC-HRMS-based multiomics to explore the potential mechanisms and biomarkers for colorectal cancer","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11306-017-1311-y","article-title":"Metabolic profiling reveals altered amino acid, energy, and lipid metabolism in ulcerative colitis","volume":"18","author":"Wang","year":"2019","journal-title":"J. Proteome Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1021\/acs.jproteome.1c00019","article-title":"Early breast cancer detection using untargeted and targeted metabolomics","volume":"20","author":"Wei","year":"2021","journal-title":"J. Proteome Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nprot.2012.024","article-title":"A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue","volume":"7","author":"Yuan","year":"2012","journal-title":"Nat. Protoc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1038\/s41596-020-0341-5","article-title":"Development of a plasma pseudotargeted metabolomics method based on ultra-high-performance liquid chromatography-mass spectrometry","volume":"15","author":"Zheng","year":"2020","journal-title":"Nat. Protoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1083788","DOI":"10.3389\/fimmu.2022.1083788","article-title":"Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1518110\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T04:46:04Z","timestamp":1733892364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1518110\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":36,"alternative-id":["10.3389\/fchem.2024.1518110"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2024.1518110","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"article-number":"1518110"}}